Bioequivalence Study of BGM0504 Injection

Clinical trial NCT07382908 · RECRUITING

Trial details

NCT number: NCT07382908
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight/Obesity

Start date: 2025-12-23
Primary completion: 2026-02-12
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.